aminocaproic acid has been researched along with Angioneurotic Edema in 23 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
Excerpt | Relevance | Reference |
---|---|---|
" A combination of aprotinin with tranexamic acid may be effective in preventing or delaying rebleeding after rupture of an intracerebral aneurysm; the addition of aprotinin seems to decrease the incidence of delayed cerebral vasospasm and ischaemic complications which are sometimes noted when tranexamic acid alone is used." | 4.77 | Clinical application of inhibitors of fibrinolysis. ( Verstraete, M, 1985) |
"The acquired angioedema is the most frequently the effect of lymphoproliferative and autoimmunological diseases." | 2.43 | [Hereditary angioedema in a 16-year-old girl]. ( Kasznia-Kocot, J; Kordys-Darmolińska, B; Kozowicz, M; Kwaśniak, A; Woś, H; Zukowska, B, 2006) |
"Hereditary angioedema is characterized by recurrent attacks of painless, non itching edema of the face and limbs and sometimes by abdominal symptoms." | 1.27 | [Hereditary angioedema. A hereditary disorder in the synthesis of the complement system]. ( Vander Eecken, P; Vanderstock, L; Vermeersch, H, 1983) |
"Hereditary angioneurotic edema, although a rare clinical entity, can be fatal if diagnosis and appropriate therapy are not instituted before the performance of routine dental and oral surgical procedures." | 1.26 | Hereditary angioneurotic edema: clinical management and case report. ( Jankowski, R; Licari, G; Mauro, JV; Meyrowitz, MR, 1982) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (60.87) | 18.7374 |
1990's | 3 (13.04) | 18.2507 |
2000's | 6 (26.09) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Farkas, H | 1 |
Harmat, G | 1 |
Füst, G | 1 |
Varga, L | 1 |
Visy, B | 1 |
EISEN, V | 1 |
Zuraw, BL | 1 |
Ritchie, BC | 1 |
Frank, MM | 1 |
Kozowicz, M | 1 |
Kordys-Darmolińska, B | 1 |
Kasznia-Kocot, J | 1 |
Woś, H | 1 |
Zukowska, B | 1 |
Kwaśniak, A | 1 |
Pedraz, J | 1 |
Daudén, E | 1 |
García-Diez, A | 1 |
Mauro, JV | 1 |
Meyrowitz, MR | 1 |
Licari, G | 1 |
Jankowski, R | 1 |
Guerrero, M | 1 |
Prieto, L | 1 |
Basomba, A | 1 |
Campos, A | 1 |
Peláez, A | 1 |
García Villalmanzo, I | 1 |
Brickman, CM | 1 |
Hosea, SW | 1 |
Sawicka, B | 1 |
Zawisza, E | 1 |
Pezko, H | 1 |
Vanderstock, L | 1 |
Vander Eecken, P | 1 |
Vermeersch, H | 1 |
Donaldson, VH | 1 |
Van Dellen, RG | 1 |
Dérer, M | 1 |
Hegyi, E | 1 |
Hauptmann, G | 1 |
Mayer, S | 1 |
Vierling, F | 1 |
Barats, JC | 1 |
Roger, S | 1 |
Hamilton, AG | 1 |
Bosley, AR | 1 |
Bowen, DJ | 1 |
Frank, M | 1 |
Gelfand, JA | 1 |
Alling, DW | 1 |
Sherins, RJ | 1 |
Madaliński, K | 2 |
Sabbouh, K | 2 |
Chorazykiewicz, M | 2 |
Gregorek, H | 1 |
Imielska, D | 1 |
Verstraete, M | 1 |
Reich, P | 1 |
Kramer, J | 1 |
Bork, K | 1 |
Alsenz, J | 1 |
Böckers, M | 1 |
Noah, E | 1 |
Loos, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Efficacy in Controlling Bleeding Post-coronary Bypass Surgery Using Combination of Local Application of Tranexamic Acid and Intravenous Tranexamic Compared to Intravenous Tranexamic Acid Alone. A Randomized Controlled Trial[NCT01600599] | 40 participants (Actual) | Interventional | 2011-01-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
8 reviews available for aminocaproic acid and Angioneurotic Edema
Article | Year |
---|---|
Clinical management of hereditary angio-oedema in children.
Topics: Adolescent; Aminocaproic Acid; Angioedema; Child; Child, Preschool; Complement C1 Inactivator Protei | 2002 |
FIBRINOLYSIS AND FORMATION OF BIOLOGICALLY ACTIVE POLYPEPTIDES.
Topics: Alpha-Globulins; Aminocaproates; Aminocaproic Acid; Anaphylaxis; Angioedema; Blood Coagulation Facto | 1964 |
Protease inhibitors in the treatment of hereditary angioedema.
Topics: Aminocaproic Acid; Angioedema; Antifibrinolytic Agents; Aprotinin; Clinical Trials as Topic; Complem | 2003 |
Hereditary angioedema: the clinical syndrome and its management in the United States.
Topics: Aminocaproic Acid; Androgens; Angioedema; Antifibrinolytic Agents; Clinical Trials as Topic; Complem | 2006 |
[Hereditary angioedema in a 16-year-old girl].
Topics: Adolescent; Aminocaproic Acid; Angioedema; Antifibrinolytic Agents; Complement C1 Inactivator Protei | 2006 |
[Practical management of C1 inhibitor deficiency].
Topics: Adolescent; Adult; Aminocaproic Acid; Angioedema; Bradykinin; Child; Child, Preschool; Complement C1 | 2007 |
Hereditary angioedema.
Topics: Adult; Aminocaproic Acid; Angioedema; Child; Complement C1 Inactivator Proteins; Danazol; Female; Hu | 1983 |
Clinical application of inhibitors of fibrinolysis.
Topics: 4-Aminobenzoic Acid; Aminocaproic Acid; Angioedema; Antifibrinolytic Agents; Aprotinin; Blood Preser | 1985 |
15 other studies available for aminocaproic acid and Angioneurotic Edema
Article | Year |
---|---|
Diagnosis and management of hereditary angioedema: an American approach.
Topics: Acute Disease; Aminocaproic Acid; Angioedema; Complement C1 Inactivator Proteins; Diagnosis, Differe | 2003 |
Hereditary angioneurotic edema: clinical management and case report.
Topics: Adult; Aminocaproic Acid; Angioedema; Dental Care for Disabled; Female; Histamine H1 Antagonists; Hu | 1982 |
[Familial angioedema (II). Treatment].
Topics: Aminocaproic Acid; Angioedema; Cinnarizine; Complement C1 Inactivator Proteins; Danazol; Histamine H | 1984 |
[Hemostasis system in patients with Quincke's edema before and after treatment with epsilon-aminocaproic acid].
Topics: Adolescent; Adult; Aged; Aminocaproates; Aminocaproic Acid; Angioedema; Female; Hemostasis; Humans; | 1984 |
[Hereditary angioedema. A hereditary disorder in the synthesis of the complement system].
Topics: Adult; Aminocaproic Acid; Angioedema; Complement Activation; Complement C1 Inactivator Proteins; Com | 1983 |
Plasminogen activation in hereditary angioneurotic edema.
Topics: Aminocaproic Acid; Angioedema; Complement System Proteins; Fibrinolysin; Humans; Plasminogen; Plasmi | 1993 |
Long-term treatment of C1 inhibitor deficiency with epsilon-aminocaproic acid in two patients.
Topics: Adult; Aminocaproic Acid; Angioedema; Antifibrinolytic Agents; Complement C1 Inactivator Proteins; F | 1996 |
[Hereditary angioedema in three members of one family (author's transl)].
Topics: Adult; Aminocaproic Acid; Angioedema; Child; Female; Humans; Male | 1979 |
[Hereditary angioneurotic oedema: preoperative prophylactic therapy with danazol].
Topics: Adult; Aminocaproic Acid; Angioedema; Complement C1 Inactivator Proteins; Complement C4; Danazol; Fe | 1978 |
Laryngeal oedema due to hereditary angioedema.
Topics: Adult; Airway Obstruction; Aminocaproic Acid; Angioedema; Exchange Transfusion, Whole Blood; Humans; | 1977 |
Epsilon aminocaproic acid for hereditary angioedema.
Topics: Aminocaproates; Aminocaproic Acid; Angioedema; Humans | 1977 |
C1-INH defect as an example of deficiency disease.
Topics: Adolescent; Adult; Aged; Aminocaproic Acid; Angioedema; Child; Child, Preschool; Complement C1 Inact | 1991 |
Familial occurrence of C1-inhibitor deficiency and the effect of treatment.
Topics: Adolescent; Aminocaproic Acid; Androgens; Angioedema; Child; Complement C1 Inactivator Proteins; Fem | 1989 |
[Andrologic aspects of the therapy of hereditary angioneurotic edema].
Topics: Adult; Aminocaproates; Aminocaproic Acid; Angioedema; Danazol; Humans; Male; Oligospermia; Pregnadie | 1986 |
[Formation of IgG antibodies to C1 inhibitor as the cause of life-threatening angioedema].
Topics: Adult; Aminocaproic Acid; Angioedema; Complement C1; Complement C1 Inactivator Proteins; Complement | 1987 |